These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1448 related items for PubMed ID: 11676830

  • 1. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
    Qin JZ, Bacon P, Chaturvedi V, Nickoloff BJ.
    J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
    [Abstract] [Full Text] [Related]

  • 2. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ.
    Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
    [Abstract] [Full Text] [Related]

  • 3. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA.
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [Abstract] [Full Text] [Related]

  • 4. Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations.
    Qin JZ, Bacon PE, Chaturvedi V, Bonish B, Nickoloff BJ.
    Exp Dermatol; 2002 Dec; 11(6):573-83. PubMed ID: 12473065
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
    Shetty S, Gladden JB, Henson ES, Hu X, Villanueva J, Haney N, Gibson SB.
    Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P, Milani D, Gonelli A, Melloni E, Campioni D, Gibellini D, Capitani S, Zauli G.
    J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
    [Abstract] [Full Text] [Related]

  • 7. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X, Kandasamy K, Srivastava RK.
    Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723
    [Abstract] [Full Text] [Related]

  • 8. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V, Bodner B, Qin JZ, Nickoloff BJ.
    J Dermatol Sci; 2006 Jan 01; 41(1):31-41. PubMed ID: 16289694
    [Abstract] [Full Text] [Related]

  • 9. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N, Hughes MA, Farrow SN, Cohen GM, MacFarlane M.
    J Biol Chem; 2003 Nov 07; 278(45):44338-47. PubMed ID: 12920112
    [Abstract] [Full Text] [Related]

  • 10. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS, Chang I, Kim JY, Choi KH, Lee MS.
    Cancer Res; 2005 Jul 15; 65(14):6111-9. PubMed ID: 16024612
    [Abstract] [Full Text] [Related]

  • 11. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 15; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 12. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K.
    Oncogene; 2003 Mar 20; 22(11):1653-62. PubMed ID: 12642868
    [Abstract] [Full Text] [Related]

  • 13. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 14. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway.
    Wang X, Ju W, Renouard J, Aden J, Belinsky SA, Lin Y.
    Cancer Res; 2006 Jan 15; 66(2):1089-95. PubMed ID: 16424045
    [Abstract] [Full Text] [Related]

  • 15. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
    Leverkus M, Neumann M, Mengling T, Rauch CT, Bröcker EB, Krammer PH, Walczak H.
    Cancer Res; 2000 Feb 01; 60(3):553-9. PubMed ID: 10676636
    [Abstract] [Full Text] [Related]

  • 16. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
    Aggarwal BB, Bhardwaj U, Takada Y.
    Vitam Horm; 2004 Feb 01; 67():453-83. PubMed ID: 15110190
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells.
    Karacay B, Sanlioglu S, Griffith TS, Sandler A, Bonthius DJ.
    Cancer Gene Ther; 2004 Oct 01; 11(10):681-90. PubMed ID: 15332116
    [Abstract] [Full Text] [Related]

  • 18. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N, Hughes M, MacFarlane M, Cohen GM.
    J Biol Chem; 2003 Jul 11; 278(28):25534-41. PubMed ID: 12721308
    [Abstract] [Full Text] [Related]

  • 19. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
    Diessenbacher P, Hupe M, Sprick MR, Kerstan A, Geserick P, Haas TL, Wachter T, Neumann M, Walczak H, Silke J, Leverkus M.
    J Invest Dermatol; 2008 May 11; 128(5):1134-47. PubMed ID: 17989734
    [Abstract] [Full Text] [Related]

  • 20. Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1.
    Bernard D, Quatannens B, Vandenbunder B, Abbadie C.
    J Biol Chem; 2001 Jul 20; 276(29):27322-8. PubMed ID: 11350953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.